Provider

At long last, Eversense, the implantable continuous glucose monitoring system from Senseonics, has received FDA clearance to be marketed in the United States.

Children with Type 1 diabetes will now have access to the Medtronic MiniMed 670G, a hybrid closed-loop system insulin delivery system, following the FDA’s decision to expand the product approval for a younger demographic.

Glucose-monitoring contact lenses have been a continuing area of interest from developers all over the world.

Earlier this week medical device maker Masimo and Thermomedics, a Positive ID company, launched their new contactless, Bluetooth-enabled thermometer in the US market.

In a recent review, an independent group of panelists raised questions about UK-based AI company DeepMind’s business model, relationship with parent company Alphabet, and potential to monopolize its industry.

Digital chronic disease management company Omada Health announced today the launch of new programs designed to support individuals with Type 2 diabetes and hypertension.

Ambient Clinical Analytics, a remote patient monitoring company that spun off from Mayo Clinic in 2013, has raised $1.

Last week the American Medical Association outlined a new set of recommendations on augmented intelligence, a type of technology that aims to extend, but not replace, a human medical expert’s insight and decision-making capabilities.

The new Rosalind Franklin Institute is investing £6m in ground-breaking initiatives that will disrupt the drug development process.

Findings from the final report of the Lord Darzi Review of Health and Care indicate advanced technologies offer an opportunity to shift the model of care from 'diagnose and treat' to 'predict and prevent', outlining a series of recommendations to accelerate access to innovation.